Japan - HealthQuill

Record-breaking heatwaves have impacted agricultural production in Japan and the East Asian nation may look at imports to meet supply shortfalls.

Heatwaves in Japan hit agricultural output, may opt for imports

HQ Team September 25, 2023: Record-breaking heatwaves have impacted agricultural production in Japan and the East Asian nation may look at imports to.

by HealthQuill
September 25, 2023
0 Comments

Eisai Co., and Biogen Inc., announced that their drug to treat Alzheimer’s disease and cognitive impairment has been approved in Japan.

Drugs Health Pharma

Japan approves Eisai Co, Biogen Inc’s Leqembi for Alzheimer’s

HQ Team September 25, 2023: Eisai Co., and Biogen Inc., announced that their drug to treat Alzheimer’s disease and cognitive impairment has been.

by HealthQuill
September 25, 2023
0 Comments

The European Commission granted Pfizer Inc., a marketing authorisation for its once-daily oral capsule to treat hair loss or alopecia aerate.

Drugs Health Pharma

Pfizer’s oral capsule Litfulo to treat hair loss gets EU approval

HQ Team September 19, 2023: The European Commission granted Pfizer Inc., a marketing authorisation for its once-daily oral capsule to treat hair loss.

by HealthQuill
September 19, 2023
0 Comments

The heat waves sweeping across the globe are the “new normal” and do not come as a surprise, Alvaro Silva, a climate expert with the World Meteorological Organization said.

Climate Health Pharma

Heatwaves across Europe, the US “new normal,” says WMO

HQ Team August 21, 2023: The heat waves sweeping across the globe are the “new normal” and do not come as a surprise,.

by HealthQuill
August 21, 2023
8 Comments

Japan’s radiologists using chest radiographs developed an AI model to accurately predict a human’s chronological age and detect chronic diseases.

Drugs Health Pharma

Japan’s radiologists invent AI model to predict age from chest graphs

HQ Team August 18, 2023: Japan’s radiologists using chest radiographs developed an AI model to accurately predict a human’s chronological age and detect.

by HealthQuill
August 18, 2023
0 Comments

The WHO has updated the EG.5 variability of the COVID-19 virus to a ‘variant of interest’ — with genetic changes that are predicted or known to affect virus characteristics, such as transmissibility, virulence, antibody evasion, susceptibility to therapeutics and detectability.

Drugs Health Pharma

WHO labels Covid-19 variant EG.5 as ‘variant of interest’; cases rise

HQ Team August 10, 2023: The WHO has updated the EG.5 variability of the COVID-19 virus to a ‘variant of interest’ — with.

by HealthQuill
August 10, 2023
0 Comments

BridgeBio Pharma Inc., a Palo Alto, California-based biopharmaceutical company, reported its late-stage trial oral drug to treat a rare heart disease condition has yielded positive results.

Drugs Health Pharma

BridgeBio says oral drug to treat rare heart disease meets trial goal

HQ Team July 17, 2023: BridgeBio Pharma Inc., a Palo Alto, California-based biopharmaceutical company, reported its late-stage trial oral drug to treat a.